Financial results - DR. SLOVENSKI S.R.L.

Financial Summary - Dr. Slovenski S.r.l.
Unique identification code: 40355967
Registration number: J35/4734/2018
Nace: 8622
Sales - Ron
1.347.515
Net Profit - Ron
2.371
Employee
22
The most important financial indicators for the company Dr. Slovenski S.r.l. - Unique Identification Number 40355967: sales in 2023 was 1.347.515 euro, registering a net profit of 2.371 euro and having an average number of 22 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dr. Slovenski S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - 13.021 151.565 740.870 1.162.164 1.229.881 1.347.515
Total Income - EUR - - - - 13.021 152.006 747.858 1.169.765 1.237.587 1.355.728
Total Expenses - EUR - - - - 0 32.494 686.821 817.239 1.109.815 1.351.094
Gross Profit/Loss - EUR - - - - 13.021 119.513 61.037 352.526 127.771 4.634
Net Profit/Loss - EUR - - - - 12.630 117.997 54.856 324.579 109.098 2.371
Employees - - - - 0 2 23 22 20 22
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 9.9%, from 1.229.881 euro in the year 2022, to 1.347.515 euro in 2023. The Net Profit decreased by -106.397 euro, from 109.098 euro in 2022, to 2.371 in the last year.

Check the financial reports for the company - Dr. Slovenski S.r.l.

Rating financiar

Financial Rating -
Dr. Slovenski S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dr. Slovenski S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dr. Slovenski S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dr. Slovenski S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dr. Slovenski S.r.l. - CUI 40355967

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - 26 41.661 188.569 161.815 210.744 172.208
Current Assets - - - - 13.064 161.899 99.416 378.012 154.925 173.945
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 13.021 138.876 60.853 290.119 41.548 82.084
Cash - - - - 43 23.023 38.563 87.893 113.377 91.860
Shareholders Funds - - - - 12.673 118.413 55.430 325.172 214.203 208.650
Social Capital - - - - 43 42 207 202 203 202
Debts - - - - 417 43.830 198.908 189.327 133.657 127.433
Income in Advance - - - - 0 41.317 33.647 25.327 17.809 10.182
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 173.945 euro in 2023 which includes Inventories of 0 euro, Receivables of 82.084 euro and cash availability of 91.860 euro.
The company's Equity was valued at 208.650 euro, while total Liabilities amounted to 127.433 euro. Equity decreased by -4.903 euro, from 214.203 euro in 2022, to 208.650 in 2023. The Debt Ratio was 36.8% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dr. Slovenski S.r.l.

Comments - Dr. Slovenski S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.